Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
Kevin Land, Interim Laboratory and Medical Director Adult HSC Lab at UPMC Hillman Cancer Center, shared a post on LinkedIn about a recent article he and his colleague co-authored, published in Transfusion, adding:
“The transfusion medicine physician has spent a career being cast as the cost-savings gatekeeper at many institutions.
Cellular therapy is handing the specialty a larger role in direct patient care.
Eric Gehrie, and I just published ‘Redefining the Role of the Transfusion Medicine Physician in the Era of Advanced Cellular Therapies’ in Transfusion – open access.
The growth in cellular collection and processing has pulled TM physicians (and the whole TM team) into new territory the specialty wasn’t necessarily trained for.
Grateful to AABB for the platform and to Eric for the collaboration.
Curious what others are seeing. Is your program stretching into cellular therapy oversight? If so, do you see anything differently than what we discussed?”
Title: Redefining the role of the transfusion medicine physician in the era of advanced cellular therapies
Authors: Eric A. Gehrie, Kevin J. Land

Other posts featuring Kevin Land on Hemostasis Today.
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C